The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
New avenues for anti-epileptic drug discovery and development
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kwan, P., Arzimanoglou, A., Berg, A. T., Brodie, M. J., Allen Hauser, W., Mathern, G., Moshé, S. L., Perucca, E., Wiebe, S., & French, J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02397.x · Cited by 4,877
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Berg, A. T., Berkovic, S. F., Brodie, M. J., Buchhalter, J., Cross, J. H., Van Emde Boas, W., Engel, J., French, J., Glauser, T. A., Mathern, G. W., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02522.x · Cited by 4,363
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
A permanent change in brain function resulting from daily electrical stimulation
Goddard, G. V., McIntyre, D. C., & Leech, C. K. (1969) · Experimental Neurology · doi:10.1016/0014-4886(69)90128-9 · Cited by 3,052
The role of inflammation in epilepsy
Vezzani, A., French, J., Bartfai, T., & Baram, T. Z. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.178 · Cited by 1,876
The neurobiology of antiepileptic drugs
Rogawski, M. A., & Löscher, W. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1430 · Cited by 1,239
Self-citationLessons from 60 years of pharmaceutical innovation
Munos, B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2961 · Cited by 1,207
Psychiatric comorbidity in epilepsy: a population-based analysis
Tellez‐Zenteno, J. F., Patten, S. B., Jetté, N., Williams, J., & Wiebe, S. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01222.x · Cited by 1,113
Is the underlying cause of epilepsy a major prognostic factor for recurrence?
Semah, F., Picot, M.-C., Adam, C., Broglin, D., Arzimanoglou, A., Bazin, B., Cavalcanti, D., & Baulac, M. (1998) · Neurology · doi:10.1212/wnl.51.5.1256 · Cited by 1,113
An integrative genomics approach to infer causal associations between gene expression and disease
Schadt, E. E., Lamb, J., Yang, X., Zhu, J., Edwards, S., GuhaThakurta, D., Sieberts, S. K., Monks, S., Reitman, M., Zhang, C., et al. (2005) · Nature Genetics · doi:10.1038/ng1589 · Cited by 1,043
On the Origin of Interictal Activity in Human Temporal Lobe Epilepsy in Vitro
Cohen, I., Navarro, V., Clemenceau, S., Baulac, M., & Miles, R. (2002) · Science · doi:10.1126/science.1076510 · Cited by 1,001
NKCC1 transporter facilitates seizures in the developing brain
Dzhala, V. I., Talos, D. M., Sdrulla, D. A., Brumback, A. C., Mathews, G. C., Benke, T. A., Delpire, E., Jensen, F. E., & Staley, K. J. (2005) · Nature Medicine · doi:10.1038/nm1301 · Cited by 981
Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., Cramp, C., Cockerell, O. C., Cooper, P. N., Doughty, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60460-7 · Cited by 976
Dysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K.-L. (2005) · Nature Genetics · doi:10.1038/ng1494 · Cited by 972
Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., Cramp, C., Cockerell, O. C., Cooper, P. N., Doughty, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60461-9 · Cited by 969
Löscher, W. (2011) · Seizure · doi:10.1016/j.seizure.2011.01.003 · Cited by 932
Self-citationPatterns of treatment response in newly diagnosed epilepsy
Brodie, M. J., Barry, S. J. E., Bamagous, G. A., Norrie, J. D., & Kwan, P. (2012) · Neurology · doi:10.1212/wnl.0b013e3182563b19 · Cited by 931
Handbook of clinical neurology
Illis, L. S. (2013) · Spinal Cord · doi:10.1038/sc.2013.79 · Cited by 910
Drug resistance in brain diseases and the role of drug efflux transporters
Löscher, W., & Potschka, H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1728 · Cited by 900
Self-citationBlood–brain barrier breakdown as a therapeutic target in traumatic brain injury
Shlosberg, D., Benifla, M., Kaufer, D., & Friedman, A. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.74 · Cited by 897
Maroso, M., Balosso, S., Ravizza, T., Liu, J., Aronica, E., Iyer, A. M., Rossetti, C., Molteni, M., Casalgrandi, M., Manfredi, A. A., et al. (2010) · Nature Medicine · doi:10.1038/nm.2127 · Cited by 842
Antiepileptic Drug Development: II. Anticonvulsant Drug Screening
Krall, R. L., Penry, J. K., White, B. G., Kupferberg, H. J., & Swinyard, E. A. (1978) · Epilepsia · doi:10.1111/j.1528-1157.1978.tb04507.x · Cited by 823
Glauser, T., Ben‐Menachem, E., Bourgeois, B., Cnaan, A., Guerreiro, C., Kälviäinen, R., Mattson, R., French, J. A., Perucca, E., Tomson, T., et al. (2013) · Epilepsia · doi:10.1111/epi.12074 · Cited by 721
Mattson, R. H., Cramer, J. A., & Collins, J. F. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209103271104 · Cited by 683
The placebo response in medicine: minimize, maximize or personalize?
Enck, P., Bingel, U., Schedlowski, M., & Rief, W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3923 · Cited by 671
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.
Zeng, L., Xu, L., Gutmann, D. H., & Wong, M. (2008) · Annals of Neurology · doi:10.1002/ana.21331 · Cited by 639
COMPARATIVE ASSAYS OF ANTIEPILEPTIC DRUGS IN MICE AND RATS
Swinyard, E. A., Brown, W. C., & Goodman, L. S. (1952) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)05100-6 · Cited by 633
Cavalheiro, E. A., Leite, J. P., Bortolotto, Z. A., Turski, W. A., Ikonomidou, C., & Turski, L. (1991) · Epilepsia · doi:10.1111/j.1528-1157.1991.tb05533.x · Cited by 616
Mechanisms of epileptogenesis and potential treatment targets
Pitkänen, A., & Lukasiuk, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70310-0 · Cited by 614
Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy
Barton, M. E., Klein, B. D., Wolf, H. H., & Steve White, H. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(01)00302-3 · Cited by 613
Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma
Löscher, W., & Schmidt, D. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03024.x · Cited by 590
Self-citationFocal seizures due to chronic localized encephalitis
Rasmussen, T., Olszewski, J., & Lloyd-Smith, D. (1958) · Neurology · doi:10.1212/wnl.8.6.435 · Cited by 560
The role of cytokines in the pathophysiology of epilepsy
Vezzani, A., Balosso, S., & Ravizza, T. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.03.009 · Cited by 558
Key factors in the discovery and development of new antiepileptic drugs
Bialer, M., & White, H. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2997 · Cited by 542
High‐frequency oscillations: What is normal and what is not?
Engel Jr, J., Bragin, A., Staba, R., & Mody, I. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01917.x · Cited by 516
A role for leukocyte-endothelial adhesion mechanisms in epilepsy
Fabene, P. F., Mora, G. N., Martinello, M., Rossi, B., Merigo, F., Ottoboni, L., Bach, S., Angiari, S., Benati, D., Chakir, A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1878 · Cited by 507
The role of inflammation in epileptogenesis
Vezzani, A., Friedman, A., & Dingledine, R. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.004 · Cited by 495
Drug Resistance in Epilepsy: Putative Neurobiologic and Clinical Mechanisms
Schmidt, D., & Löscher, W. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.54904.x · Cited by 482
Self-citationProgress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E., & Tomson, T. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.10.008 · Cited by 477
Vezzani, A., Moneta, D., Conti, M., Richichi, C., Ravizza, T., De Luigi, A., De Simoni, M. G., Sperk, G., Andell-Jonsson, S., Lundkvist, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190206797 · Cited by 464
Scannevin, R. H., Chollate, S., Jung, M.-Y., Shackett, M., Patel, H., Bista, P., Zeng, W., Ryan, S., Yamamoto, M., Lukashev, M., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.190132 · Cited by 461
Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects
Jimenez-Mateos, E. M., Engel, T., Merino-Serrais, P., McKiernan, R. C., Tanaka, K., Mouri, G., Sano, T., O'Tuathaigh, C., Waddington, J. L., Prenter, S., et al. (2012) · Nature Medicine · doi:10.1038/nm.2834 · Cited by 459
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
Rogawski, M. A., & Löscher, W. (2004) · Nature Medicine · doi:10.1038/nm1074 · Cited by 456
Self-citationLöscher, W., & Brandt, C. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003046 · Cited by 414
Self-citationNatural history of treated childhood-onset epilepsy: prospective, long-term population-based study
Sillanpää, M., & Schmidt, D. (2006) · Brain · doi:10.1093/brain/awh726 · Cited by 414
Self-citationMolecular and cellular mechanisms of pharmacoresistance in epilepsy
Remy, S., & Beck, H. (2006) · Brain · doi:10.1093/brain/awh682 · Cited by 406
Vezzani, A., Moneta, D., Richichi, C., Aliprandi, M., Burrows, S. J., Ravizza, T., Perego, C., & De Simoni, M. G. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.5.14.x · Cited by 386
Enzyme induction with antiepileptic drugs: Cause for concern?
Brodie, M. J., Mintzer, S., Pack, A. M., Gidal, B. E., Vecht, C. J., & Schmidt, D. (2013) · Epilepsia · doi:10.1111/j.1528-1167.2012.03671.x · Cited by 383
Self-citationTranscriptome Profiling Reveals TGF- Signaling Involvement in Epileptogenesis
Cacheaux, L. P., Ivens, S., David, Y., Lakhter, A. J., Bar-Klein, G., Shapira, M., Heinemann, U., Friedman, A., & Kaufer, D. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0430-09.2009 · Cited by 383
Vezzani, A., Maroso, M., Balosso, S., Sanchez, M.-A., & Bartfai, T. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.03.018 · Cited by 362
Multiple facets of GABAergic neurons and synapses: multiple fates of GABA signalling in epilepsies
Cossart, R., Bernard, C., & Ben-Ari, Y. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2004.11.011 · Cited by 342
Development of new antiepileptic drugs: challenges, incentives, and recent advances
Perucca, E., French, J., & Bialer, M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70215-6 · Cited by 339
Ryvlin, P., Cucherat, M., & Rheims, S. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70193-4 · Cited by 338
Preventing and treating posttraumatic seizures: The human experience
Temkin, N. R. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.02005.x · Cited by 329
Quantifying the response to antiepileptic drugs: Effect of past treatment history
Schiller, Y., & Najjar, Y. (2008) · Neurology · doi:10.1212/01.wnl.0000286959.22040.6e · Cited by 313
Experimental Determination of the Anticonvulsant Properties of Some Phenyl Derivatives
Putnam, T. J., & Merritt, H. H. (1937) · Science · doi:10.1126/science.85.2213.525 · Cited by 306
Vergnes, M., Marescaux, C., Micheletti, G., Reis, J., Depaulis, A., Rumbach, L., & Warter, J. M. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90136-7 · Cited by 300
Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E., & Tomson, T. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2004.07.010 · Cited by 300
Maroso, M., Balosso, S., Ravizza, T., Iori, V., Wright, C. I., French, J., & Vezzani, A. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0039-z · Cited by 297
Treatment of pediatric epilepsy: European expert opinion, 2007
Wheless, J. W., Clarke, D. F., Arzimanoglou, A., & Carpenter, D. (2007) · Epileptic Disorders · doi:10.1684/epd.2007.0144 · Cited by 295
Engel, J., Jr., Thompson, P. M., Stern, J. M., Staba, R. J., Bragin, A., & Mody, I. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835ee5b8 · Cited by 283
The clinical impact of pharmacogenetics on the treatment of epilepsy
Löscher, W., Klotz, U., Zimprich, F., & Schmidt, D. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01716.x · Cited by 281
Self-citationThe State of Innovation in Drug Development
Kola, I. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100479 · Cited by 276
Löscher, W., Puskarjov, M., & Kaila, K. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.045 · Cited by 271
Self-citationFriedman, A., Kaufer, D., & Heinemann, U. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.03.005 · Cited by 270
Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage
Librizzi, L., Noè, F., Vezzani, A., de Curtis, M., & Ravizza, T. (2012) · Annals of Neurology · doi:10.1002/ana.23567 · Cited by 253
Blood‐brain barrier dysfunction, TGFβ signaling, and astrocyte dysfunction in epilepsy
Heinemann, U., Kaufer, D., & Friedman, A. (2012) · Glia · doi:10.1002/glia.22311 · Cited by 253
New Roles for Interleukin-1 Beta in the Mechanisms of Epilepsy
Vezzani, A., & Baram, T. Z. (2007) · Epilepsy Currents · doi:10.1111/j.1535-7511.2007.00165.x · Cited by 250
Privitera, M. D., Brodie, M. J., Mattson, R. H., Chadwick, D. W., Neto, W., Wang, S., & for the EPMN 105 Study Group (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00093.x · Cited by 249
Combining antiepileptic drugs—Rational polytherapy?
Brodie, M. J., & Sills, G. J. (2011) · Seizure · doi:10.1016/j.seizure.2011.01.004 · Cited by 244
Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)
Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2013) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.10.001 · Cited by 243
The transport of antiepileptic drugs by P-glycoprotein
Zhang, C., Kwan, P., Zuo, Z., & Baum, L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.003 · Cited by 225
Brandt, C., Bethmann, K., Gastens, A. M., & Löscher, W. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.014 · Cited by 221
Self-citationLöscher, W., & Schmidt, D. (1994) · Epilepsy Research · doi:10.1016/0920-1211(94)90012-4 · Cited by 221
Self-citationPharmacoresistance and the role of surgery in difficult to treat epilepsy
Wiebe, S., & Jette, N. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.181 · Cited by 207
Early treatment suppresses the development of spike‐wave epilepsy in a rat model
Blumenfeld, H., Klein, J. P., Schridde, U., Vestal, M., Rice, T., Khera, D. S., Bashyal, C., Giblin, K., Paul‐Laughinghouse, C., Wang, F., et al. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2007.01458.x · Cited by 206
McClelland, S., Flynn, C., Dubé, C., Richichi, C., Zha, Q., Ghestem, A., Esclapez, M., Bernard, C., & Baram, T. Z. (2011) · Annals of Neurology · doi:10.1002/ana.22479 · Cited by 186
Bertram, E. H., Zhang, D. X., Mangan, P., Fountain, N., & Rempe, D. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(98)00051-5 · Cited by 182
P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study
Feldmann, M., Asselin, M.-C., Liu, J., Wang, S., McMahon, A., Anton-Rodriguez, J., Walker, M., Symms, M., Brown, G., Hinz, R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70109-1 · Cited by 181
Brandt, C., Nozadze, M., Heuchert, N., Rattka, M., & Loscher, W. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0633-10.2010 · Cited by 179
Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X)
Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.09.001 · Cited by 179
Drug treatment of epilepsy: Options and limitations
Schmidt, D. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.02.030 · Cited by 177
Self-citationGABAergic excitation after febrile seizures induces ectopic granule cells and adult epilepsy
Koyama, R., Tao, K., Sasaki, T., Ichikawa, J., Miyamoto, D., Muramatsu, R., Matsuki, N., & Ikegaya, Y. (2012) · Nature Medicine · doi:10.1038/nm.2850 · Cited by 172
Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy
Sillanpaa, M., & Schmidt, D. (2008) · Brain · doi:10.1093/brain/awn357 · Cited by 163
Self-citationHampel, H. J., Lista, S., & Khachaturian, Z. S. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.2116 · Cited by 152
Beyenburg, S., Stavem, K., & Schmidt, D. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02299.x · Cited by 149
Self-citationLöscher, W., Luna‐Tortós, C., Römermann, K., & Fedrowitz, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797440212 · Cited by 149
Self-citationMula, M., Kanner, A. M., Schmitz, B., & Schachter, S. C. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03688.x · Cited by 147
Kanner, A. M. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70201-6 · Cited by 143
Adverse effects of antiepileptic drugs
Perucca, E., & Meador, K. J. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00506.x · Cited by 142
Hazards of Inference: The Active Control Investigation
Leber, P. D. (1989) · Epilepsia · doi:10.1111/j.1528-1157.1989.tb05816.x · Cited by 138
Antiepileptic drug therapy: Does mechanism of action matter?
Brodie, M. J., Covanis, A., Gil‐Nagel, A., Lerche, H., Perucca, E., Sills, G. J., & White, H. S. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.05.025 · Cited by 134
Nrf2 defense pathway: Experimental evidence for its protective role in epilepsy
Mazzuferi, M., Kumar, G., van Eyll, J. M., Danis, B., Foerch, P., & Kaminski, R. M. (2013) · Annals of Neurology · doi:10.1002/ana.23940 · Cited by 132
Everett, G. M., & Richards, R. K. (1944) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)08929-3 · Cited by 130
Löscher, W., & Rundfeldt, C. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20238-5 · Cited by 126
Self-citationTrinka, E., Marson, A. G., Van Paesschen, W., Kälviäinen, R., Marovac, J., Duncan, B., Buyle, S., Hallström, Y., Hon, P., Muscas, G. C., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300376 · Cited by 121
Frigerio, F., Frasca, A., Weissberg, I., Parrella, S., Friedman, A., Vezzani, A., & Noè, F. M. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03666.x · Cited by 120
Russo, E., Citraro, R., Donato, G., Camastra, C., Iuliano, R., Cuzzocrea, S., Constanti, A., & Sarro, G. D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.09.019 · Cited by 117
Lasoń, W., Dudra-Jastrzębska, M., Rejdak, K., & Czuczwar, S. J. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70497-2 · Cited by 117
Bumetanide reduces seizure frequency in patients with temporal lobe epilepsy
Eftekhari, S., Habibabadi, J. M., Ziarani, M. N., Fesharaki, S. S. H., Gharakhani, M., Mostafavi, H., Joghataei, M. T., Beladimoghadam, N., Rahimian, E., & Hadjighassem, M. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03654.x · Cited by 114
Evidence-based review on the natural history of the epilepsies
Schmidt, D., & Sillanpää, M. L. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283507e73 · Cited by 114
Self-citationThe intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs
Rogawski, M. A. (2013) · Epilepsia · doi:10.1111/epi.12182 · Cited by 110
The emerging role of DNA methylation in epileptogenesis
Kobow, K., & Blümcke, I. (2012) · Epilepsia · doi:10.1111/epi.12031 · Cited by 109
Kraft, A. D., Lee, J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04019.x · Cited by 108
New Developments in Antiepileptic Drug Resistance: An Integrative View
Schmidt, D., & Löscher, W. (2009) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7511.2008.01289.x · Cited by 108
Self-citationFinding a better drug for epilepsy: Antiepileptogenesis targets
Kobow, K., Auvin, S., Jensen, F. E., Löscher, W., Módy, I., Potschka, H., Prince, D. A., Sierra, A., Simonato, M., Pitkänen, A., et al. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03716.x · Cited by 107
Self-citationSloviter, R. S., & Bumanglag, A. V. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.022 · Cited by 105
Benefit of combination therapy in epilepsy: A review of the preclinical evidence with levetiracetam
Kaminski, R. M., Matagne, A., Patsalos, P. N., & Klitgaard, H. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01713.x · Cited by 103
Self-citationSwinyard, E. A. (1949) · Journal of the American Pharmaceutical Association (Scientific ed ) · doi:10.1002/jps.3030380409 · Cited by 103
Antiepileptic Drug Development: I. History and a Program for Progress
Krall, R. L., PENRY, J. K., Kupferberg, H. J., & Swinyard, E. A. (1978) · Epilepsia · doi:10.1111/j.1528-1157.1978.tb04506.x · Cited by 100
Löscher, W., Rundfeldt, C., & Hönack, D. (1993) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1993.tb00224.x · Cited by 99
Self-citationKwon, Y. S., Pineda, E., Auvin, S., Shin, D. H., Mazarati, A. M., & Sankar, R. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-30 · Cited by 94
Brandt, C., Volk, H. A., & Löscher, W. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.16904.x · Cited by 93
Self-citationRoopra, A., Dingledine, R. J., & Hsieh, J. (2012) · Epilepsia · doi:10.1111/epi.12030 · Cited by 92
Increased Risk of Death Among Children With Lennox-Gastaut Syndrome and Infantile Spasms
Autry, A. R., Trevathan, E., Braun, K. V. N., & Yeargin‐Allsopp, M. (2009) · Journal of Child Neurology · doi:10.1177/0883073809348355 · Cited by 89
Basic mechanisms of seizure propagation: targets for rational drug design and rational polypharmacy.
Löscher, W., & Ebert, U. (1996) · PubMed · Cited by 88
Self-citationSzot, P. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03476.x · Cited by 87
Epileptogenesis-related genes revisited
Łukasiuk, K., Dąbrowski, M., Adach, A., & Pitkänen, A. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)58011-2 · Cited by 87
Russo, E., Citraro, R., Scicchitano, F., Fazio, S. D., Paola, E. D. D., Constanti, A., & Sarro, G. D. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02400.x · Cited by 86
Potschka, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.007 · Cited by 81
Finding a better drug for epilepsy: Preclinical screening strategies and experimental trial design
Simonato, M., Löscher, W., Cole, A. J., Dudek, F. E., Engel, J., Kaminski, R. M., Loeb, J. A., Scharfman, H. E., Staley, K. J., Velı́šek, L., et al. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03541.x · Cited by 79
Self-citationA Systems Level, Functional Genomics Analysis of Chronic Epilepsy
Winden, K. D., Karsten, S. L., Bragin, A., Kudo, L. C., Gehman, L., Ruidera, J., Geschwind, D. H., & Engel, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020763 · Cited by 76
Dopamine abnormalities in the neocortex of patients with temporal lobe epilepsy
Rocha, L., Alonso‐Vanegas, M., Villeda‐Hernández, J., Mújica, M., Cisneros-Franco, J. M., Lopez-Gómez, M., Zavala‐Tecuapetla, C., Frías‐Soria, C. L., Segovia‐Vila, J., & Borsodi, A. D. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.006 · Cited by 73
Srivastava, A. K., & White, H. S. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.10.003 · Cited by 72
Biomarkers in Epilepsy: Introduction
Engel, J. (2011) · Biomarkers in Medicine · doi:10.2217/bmm.11.62 · Cited by 70
Levetiracetam: the first SV2A ligand for the treatment of epilepsy
Klitgaard, H., & Verdru, P. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.11.1537 · Cited by 68
Self-citationDo preclinical seizure models preselect certain adverse effects of antiepileptic drugs
Meldrum, B. S. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00066-9 · Cited by 63
Leukocyte trafficking mechanisms in epilepsy
Fabene, P. F., Laudanna, C., & Constantin, G. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2012.12.009 · Cited by 62
Ryther, R. C. C., & Wong, M. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0276-5 · Cited by 60
Perampanel—new promise for refractory epilepsy?
Löscher, W., & Schmidt, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.222 · Cited by 58
Self-citationAinsworth, C. (2011) · Nature Medicine · doi:10.1038/nm1011-1166 · Cited by 55
Identifying targets for preventing epilepsy using systems biology
Loeb, J. A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.02.041 · Cited by 53
Human clinical trails in antiepileptogenesis
Mani, R., Pollard, J., & Dichter, M. A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.03.010 · Cited by 51
Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report
Sotgiu, S., Murrighile, M. R., & Constantin, G. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-84 · Cited by 50
Is antiepileptogenesis a realistic goal in clinical trials? Concerns and new horizons*
Schmidt, D. (2012) · Epileptic Disorders · doi:10.1684/epd.2012.0512 · Cited by 47
Self-citationUse of epileptic animals for adverse effect testing
Klitgaard, H., Matagne, A., & Lamberty, Y. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00068-2 · Cited by 45
Self-citationSystems biology impact on antiepileptic drug discovery
Margineanu, D. G. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.10.006 · Cited by 42
Pharmacodynamic interactions between antiepileptic drugs: preclinical data based on isobolography
Czuczwar, S. J., Kaplanski, J., Swiderska-Dziewit, G., Gergont, A., Kroczka, S., & Kaciński, M. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250802677826 · Cited by 37
Perucca, E. (2012) · Epileptic Disorders · doi:10.1684/epd.2012.0511 · Cited by 37
White, H. S., Smith-Yockman, M., SRIVASTAVA, A., & Wilcox, K. S. (2006) · Elsevier eBooks · doi:10.1016/b978-012088554-1/50046-3 · Cited by 37
Friedman, D. J., & French, J. A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70177-1 · Cited by 34
The Pharmacology of New Antiepileptic Drugs: Does a Novel Mechanism of Action Really Matter?
Perucca, E. (2011) · CNS Drugs · doi:10.2165/11587900-000000000-00000 · Cited by 34
Feldmann, M., & Koepp, M. J. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03704.x · Cited by 31
Kobeissy, F. H., Guingab-Cagmat, J. D., Razafsha, M., O'Steen, L. E., Zhang, Z., Hayes, R. L., Chiu, W., & Wang, K. (2011) · PM&R · doi:10.1016/j.pmrj.2011.02.012 · Cited by 30
Before Epilepsy Unfolds: Finding the epileptogenesis switch
Vezzani, A. (2012) · Nature Medicine · doi:10.1038/nm.2982 · Cited by 26
Clinical trials for prevention of epileptogenesis
Herman, S. T. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.09.015 · Cited by 25
Stiripentol: In Severe Myoclonic Epilepsy of Infancy (Dravet Syndrome)
Plosker, G. L. (2012) · CNS Drugs · doi:10.1007/s40263-012-0004-3 · Cited by 25
Sloviter, R. S. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.038 · Cited by 22
Lamotrigine (Lamictal IR) for the treatment of bipolar disorder
Bowden, C. L., & Singh, V. K. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.741590 · Cited by 20
Abou-Khalil, B. W., & Schmidt, D. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52899-5.00024-1 · Cited by 17
Self-citation
Cited by
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
Self-citationInfections, inflammation and epilepsy
Vezzani, A., Fujinami, R. S., White, H. S., Preux, P.-M., Blümcke, I., Sander, J. W., & Löscher, W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1481-5 · Cited by 518
Self-citationTalevi, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00205 · Cited by 381
Löscher, W. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2222-z · Cited by 367
Self-citationLöscher, W., & Klein, P. (2021) · CNS Drugs · doi:10.1007/s40263-021-00827-8 · Cited by 367
Self-citation
Metadata
- Authors
- Löscher, W., Klitgaard, H., Twyman, R. E., & Schmidt, D.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2013-09-20
- Volume
- 12
- Issue
- 10
- Pages
- 757-776
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1970117905
- Cited by
- 675
- References
- 152
- FWCI
- 7.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.